SEC Form 4 · accession 0001225208-15-011270

Merck & Co., Inc. · MRK

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — Exe V-P & Gen Counsel

Period of report

May 1, 2015

Accepted (ET)

May 5, 2015 · 4:46 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0000310158

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock	May 2, 2015	M	11,708	$0.00	A	156,503	D
Common Stock	May 2, 2015	F	6,071	$59.86	D	150,432	D
Common Stock	May 4, 2015	M	56,064	$39.29	A	206,496	D
Common Stock^F1,F2	May 4, 2015	S	56,064	$60.1954	D	150,432	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Stock Option (right to buy)^F3	$59.86	May 1, 2015	A	142,415	A	May 1, 2016	Apr 30, 2025	Common Stock	142,415	142,415	D
Restricted Stock Unit^F4	—	May 2, 2015	M	11,708	D	May 2, 2015	May 2, 2015	Common Stock	11,708	0	D
Stock Option (right to buy)^F5	$39.29	May 4, 2015	M	56,064	D	May 2, 2013	May 1, 2022	Common Stock	56,064	0	D

F1The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.0500 to $60.4200, inclusive. The reporting person undertakes to provide to Merck & Co., Inc., any security holder of Merck & Co., Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above in this footnote.
F2Holdings include shares acquired in dividend reinvestment transactions.
F3The option vests and becomes exercisable in three equal installments on 5/1/2016, 5/1/2017 and 5/1/2018.
F4Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.
F5The option vested and became exercisable in three equal installments on 5/2/2013, 5/2/2014 and 5/2/2015.